Eli Lilly’s GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory approval is planned for 2025.
New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval
Related Posts
-
Iowa football vs. Albany: How to watch and stream the Hawkeyes’ 2025 opener
A highly anticipated season gets underway this Saturday at Kinnick Stadium against a new opponent.
-
Fed Governor Cook’s attorney says he will file suit over Trump’s attempt to fire her
Federal Reserve Governor Lisa Cook is fighting back after Trump’s attempt to fire her
-
Hidden dangers: The risk of America’s aging dams
More than 50 years after the Buffalo Creek dam disaster killed 125 people, experts warn…
-
What Taylor Swift and Travis Kelce were wearing during engagement
The singer hard-launched the announcement on Instagram this afternoon.
Leave a Reply